Loading
A phase 1 trial of PLX-61639 run by Plexium, Inc., now recruiting.
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors is a phase 1 interventional study registered as NCT07284186 by Plexium, Inc., with 155 participants planned, started 2025-12-01. Conditions recorded: Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastric Squamous Cell Carcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Metastatic Solid Tumor, Non-Small Cell Lung Carcinoma, Esophageal Adenocarcinoma, SMARCA4 Mutation, Gastroesophageal Junction Squamous Cell Carcinoma and Advanced Solid Tumor. Interventions recorded: PLX-61639.
Shares Plexium, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Plexium, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Oesophageal squamous cell carcinoma, Oesophageal and junctional adenocarcinoma, Gastric & gastro-oesophageal junction cancer, Non-small-cell lung cancer and the tag pipeline.
Shares Oesophageal squamous cell carcinoma, Oesophageal and junctional adenocarcinoma, Gastric & gastro-oesophageal junction cancer, Non-small-cell lung cancer and the tag pipeline.
Shares Oesophageal squamous cell carcinoma, Oesophageal and junctional adenocarcinoma and the tag pipeline.
Shares Oesophageal squamous cell carcinoma, Gastric & gastro-oesophageal junction cancer, Metastatic cancer (cancer that has spread), Non-small-cell lung cancer and the tag pipeline.
Shares Oesophageal and junctional adenocarcinoma, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
Shares Oesophageal and junctional adenocarcinoma, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/